Instalab
logoInstalab

8-Hydroxyguanosine

Urine Test
Track oxidative RNA damage over time, with the strongest human outcome data in type 2 diabetes.
4.9 (4,029 reviews)
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Collect your sample
At home
Get results
Explained with clear next steps, no medical jargon

Should you take a 8-OHGuo test?

This test is most useful if any of these apply to you.

Watching How You're Aging
You feel well and want an exploratory trend on RNA oxidation as you age.
Managing Type 2 Diabetes
You have type 2 diabetes and want an extra risk signal alongside glucose and kidney markers.
Exposed to Fumes or Pollution
You work around copier emissions, fumes, smoke, or heavy pollution that may raise urinary RNA-damage markers.
Feeling Yourself Slow With Age
You are losing strength or stamina, and want a research-grade marker tied to frailty in older heart-disease patients.

About 8-Hydroxyguanosine

Every day, the work of turning food and oxygen into energy throws off reactive fragments that can damage the genetic material inside your cells. This test measures one specific piece of that damage in urine: 8-OHG. Research papers often call the same molecule 8-oxoGuo or 8-oxoGsn. Most studies interpret it after correction for creatinine, because urine concentration changes from sample to sample.

The strongest evidence is in type 2 diabetes. In several human cohorts, people excreting more urinary 8-oxoGuo were more likely to die in the following years. The RNA marker often carried a sharper signal than the better-known DNA-damage version.

What This Marker Actually Captures

8-OHG is short for 8-hydroxyguanosine. It forms when reactive oxygen chemistry hits guanine inside RNA. Guanine is one of the four chemical letters in RNA.

RNA takes these hits more often than DNA. It is single-stranded, less protected, and often close to mitochondria. Mitochondria make most of your cell's energy, and that energy work produces much of the reactive oxygen chemistry this marker is trying to catch.

The exact source of urinary 8-OHG is not fully pinned down. It probably comes from damaged RNA and from cleanup of damaged RNA building blocks. That uncertainty matters: the result is best read as a whole-body signal of RNA oxidation, not a readout from one organ or one repair enzyme.

It has a close twin: 8-OHdG. That marker reflects DNA oxidation. The two differ by one sugar and are often measured side by side, but they are not interchangeable. In several settings, the RNA version has been the more informative of the two.

Type 2 Diabetes and Early Death

In 970 people with established and treated type 2 diabetes, urinary 8-oxoGuo predicted death over nearly 10 years. The DNA version did not. A larger prospective study of 1,863 older adults with type 2 diabetes found the same pattern for death from any cause and death from heart disease.

Adding this marker may sharpen risk estimates, but clinical utility is not settled. In 1,381 people followed for 19 years after diabetes diagnosis, pairing urinary 8-oxoGuo with urinary albumin identified high-risk people better than either measure alone. Urinary albumin is a standard marker of kidney damage.

If you live with type 2 diabetes, a high reading is a reason to look harder at the known drivers of risk: glucose, kidney filtration, urine albumin, blood pressure, ApoB or LDL, and smoking. It is not a diagnosis by itself.

Aging and Physical Decline

In a cross-sectional study of 1,228 healthy Chinese residents, urinary 8-oxoGuo rose across the adult decades and ran about twice as high as its DNA twin for a given person. That makes it one of the few oxidative-damage markers with a clear age pattern in the same molecule and urine sample this test uses. It is still not a clinical aging clock.

It also tracks how well the body is holding up, not just how many years have passed. Among 508 older adults with heart disease, this RNA marker was independently linked to frailty, while the DNA version was not. Two people the same age can carry different amounts of this signal, and that difference may matter.

Serious Illness and the Lungs

A 315-person study included healthy controls, people with COPD, and patients on mechanical ventilation. COPD is a long-term lung disease that makes breathing harder. Urinary 8-oxoGuo separated the sick from the healthy about 91 times out of 100. That beat the DNA-damage version, which scored about 80 out of 100, and MDA, a fat-oxidation marker that failed to distinguish the groups.

This does not make 8-OHG a lung-disease test. It shows that severe illness and lung stress can raise this RNA-oxidation signal.

Cancer

In 130 people, urinary 8-OHG and its DNA twin were both higher in gastric cancer patients than in healthy controls. That is why the marker has been studied as a possible non-invasive cancer signal. Read alone, that seems to say higher is worse.

A large nested case-control study complicates that reading. Across 2,189 colorectal cancer cases plus matched controls, the relationship between urinary nucleic-acid oxidation and future colorectal cancer was time-dependent. For cancers diagnosed within five years, higher oxidation was linked to lower risk. For cancers diagnosed later, there was no clear link.

So this is not a clean high-equals-future-cancer number. Higher readings in people who already have cancer may reflect cancer-related biology or other differences between cases and controls. In a healthy person, the link to a specific future cancer is unsettled. Treat this as a marker of an ongoing biological process, not a cancer test.

Pollution, Smoke, and Workplace Exposure

External exposures can raise this marker. In a small study of photocopier emissions, urinary 8-OHG rose after a six-hour exposure and kept rising for up to 36 hours. By that point, it was nearly four times the pre-exposure level. The timing matters: a sample drawn right after an exposure can miss the delayed peak.

This is a timing lesson, not a personal risk calculator. The acute study had nine volunteers, and the chronic worker comparison was small.

Why One Reading Tells You Little

A single number here is noisy. Urine concentration swings from day to day, so the raw value can move even when your biology has not. Creatinine correction helps. In one five-day sampling study, creatinine correction cut within-person variation sharply. For this RNA marker, a follow-up reading had to change by more than about a third to clear expected short-term variation.

That is why this marker makes more sense as a trend. One value can raise a question. A series can show whether the signal is staying high, falling, or drifting up.

When a Reading Can Mislead You

  • Kidney function: kidney disease can change production, filtering, and excretion, so read the result with eGFR and urine albumin.
  • Hydration and creatinine correction: a dilute or concentrated sample can change the raw urine concentration without changing oxidative RNA damage.
  • Lab handling: one LC-MS method found that incompletely redissolved frozen urine sediment could underread 8-OHG by up to 86 percent.
  • Age and sex: levels rise with age, and sex differences appear after about age 60 in one large Chinese cohort.
  • Method mismatch: ELISA antibody results and LC-MS/MS results should not be trended together.

What Moves This Biomarker

Evidence-backed interventions that affect your 8-OHGuo level

↓ Decrease
Intensive exercise-based lifestyle program
An intensive exercise-based lifestyle program lowered urinary 8-oxoGuo, the RNA-oxidation marker this test reports. In a randomized trial of 77 adults with type 2 diabetes, the 12-month program lowered 8-oxoGuo by about 7 percent, while standard care rose by about 8.5 percent. The DNA-damage version did not change.
ExerciseModest Evidence

Frequently Asked Questions

Panels containing 8-OHGuo

8-Hydroxyguanosine is included in these pre-built panels.

References

19 studies
  1. Ying-ming Shih, M. Cooke, C. Pan, M. Chao, Chiung-wen HuRedox Biology2018
  2. Wei Gan, Xinle Liu, Ting Yu, Yuangao Zou, Ting-ting Li, Shuang-hu Wang, Jin Deng, Lan-lan Wang, Jian-ping CaiFrontiers in Aging Neuroscience2018
  3. Yaodan Liang, Qian Liu, M. Du, Zhen Liu, S. Yao, P. Zheng, Yuhao Wan, N. Sun, Ying-ying Li, Junpeng Liu, Yao Luo, Jian-ping Cai, Jiefu Yang, Hua WangFree Radical Biology & Medicine2020
  4. K. Broedbaek, V. Siersma, T. Henriksen, a. Weimann, M. Petersen, J. Andersen, E. Jimenez-solem, L. Hansen, J. Henriksen, S. Bonnema, N. De Fine Olivarius, H. PoulsenDiabetes Care2013
  5. Laura K. Kjaer, Vanja Cejvanovic, T. Henriksen, K. M. Petersen, T. Hansen, O. Pedersen, C. Christensen, C. Torp-pedersen, T. Gerds, I. Brandslund, T. Mandrup-poulsen, H. PoulsenDiabetes Care2017